Thermo Fisher Scientific Inc (TMO) Covered Calls

Thermo Fisher Scientific Inc covered calls Thermo Fisher Scientific Inc. is the global leader in serving science, providing an unrivaled portfolio of innovative technologies and pharmaceutical services. The company supports customers in accelerating life sciences research, solving complex analytical challenges, and improving patient health through advanced diagnostics. Operating through premier brands like Thermo Scientific and Invitrogen, it offers essential laboratory equipment, reagents, and clinical research solutions.

You can sell covered calls on Thermo Fisher Scientific Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for TMO (prices last updated Thu 4:16 PM ET):

Thermo Fisher Scientific Inc (TMO) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
509.82 -17.35 496.80 509.00 4.7M 31 198
Covered Calls For Thermo Fisher Scientific Inc (TMO)
Expiration Strike Call Bid Net Debit Return
If Flat		 Annualized
Return If Flat
Feb 20 510 10.30 498.70 2.1% 85.2%
Mar 20 510 21.30 487.70 4.4% 43.4%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Core Business and Products

Thermo Fisher Scientific operates a massive, integrated ecosystem that supports the entire lifecycle of scientific discovery and healthcare delivery. Its business is built on a "trusted partner" model, providing end-to-end solutions for pharmaceutical, biotech, and academic customers. Their primary segments include:

  1. Life Sciences Solutions: High-impact reagents, consumables, and instruments used in biological research and the production of new drugs and vaccines.
  2. Analytical Instruments: Next-generation technologies such as the Orbitrap mass spectrometers and electron microscopy for complex disease research.
  3. Specialty Diagnostics: Clinical diagnostic test kits, reagents, and culture media used in hospitals and laboratories to improve patient outcomes.
  4. Laboratory Products and Biopharma Services: Essential lab supplies and outsourced clinical research capabilities following the integration of PPD and expansion of sterile fill-finish sites.

Competitive Landscape

As a dominant force in the life sciences tools sector, Thermo Fisher competes with other large-cap diversified technology and medical firms. Its most significant direct rivals are Danaher Corporation and Agilent Technologies, both of which offer competing analytical and diagnostic platforms. In the specialized clinical research and biopharma service markets, it encounters competition from IQVIA Holdings and Medpace Holdings. Additionally, in specific diagnostic niches and medical instrumentation, it competes with global giants like Abbott Laboratories and Becton, Dickinson and Company.

Strategic Outlook and Innovation

Thermo Fisher is currently executing a strategy focused on AI-Enabled Science, highlighted by recent collaborations with NVIDIA to integrate generative AI into scientific instrumentation. This initiative aims to accelerate laboratory performance and data interpretation, transforming raw data into actionable insights in real-time. Innovation efforts are also directed toward Precision Medicine, with the rollout of the EXENT system for blood-based diagnostics and new chromatography products for micro-chip-based analysis. The company is actively expanding its high-growth bioprocess design centers in Asia and investing in U.S. sterile packaging capacity to support the reshoring of drug manufacturing. By leveraging its PPI Business System for operational excellence and maintaining a disciplined capital deployment strategy—including synergistic acquisitions in purification and filtration—the company seeks to drive long-term value and support the global transition toward personalized healthcare.